Galli, Mattia
 Distribuzione geografica
Continente #
NA - Nord America 2.314
AS - Asia 1.482
EU - Europa 1.136
SA - Sud America 284
Continente sconosciuto - Info sul continente non disponibili 66
AF - Africa 40
OC - Oceania 9
Totale 5.331
Nazione #
US - Stati Uniti d'America 2.261
SG - Singapore 712
CN - Cina 273
SE - Svezia 260
IT - Italia 230
BR - Brasile 226
VN - Vietnam 185
FR - Francia 150
DE - Germania 139
IE - Irlanda 75
IN - India 52
JP - Giappone 51
GB - Regno Unito 50
ID - Indonesia 50
FI - Finlandia 47
PL - Polonia 46
HK - Hong Kong 42
RU - Federazione Russa 33
CA - Canada 26
IQ - Iraq 22
UA - Ucraina 22
NL - Olanda 20
AR - Argentina 19
BD - Bangladesh 18
MX - Messico 16
AT - Austria 12
CZ - Repubblica Ceca 11
ET - Etiopia 11
AU - Australia 9
CI - Costa d'Avorio 9
IR - Iran 9
CO - Colombia 8
KR - Corea 8
PK - Pakistan 8
TR - Turchia 8
VE - Venezuela 8
ZA - Sudafrica 8
BE - Belgio 6
LT - Lituania 6
PY - Paraguay 6
AZ - Azerbaigian 5
EC - Ecuador 5
JM - Giamaica 5
UY - Uruguay 5
AE - Emirati Arabi Uniti 4
BG - Bulgaria 4
CH - Svizzera 4
ES - Italia 4
IL - Israele 4
JO - Giordania 4
PT - Portogallo 4
QA - Qatar 4
CL - Cile 3
EG - Egitto 3
EU - Europa 3
MA - Marocco 3
NP - Nepal 3
SA - Arabia Saudita 3
TW - Taiwan 3
UZ - Uzbekistan 3
AL - Albania 2
HN - Honduras 2
KE - Kenya 2
KZ - Kazakistan 2
MY - Malesia 2
PH - Filippine 2
SI - Slovenia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BO - Bolivia 1
CR - Costa Rica 1
CV - Capo Verde 1
CY - Cipro 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
GR - Grecia 1
GT - Guatemala 1
GY - Guiana 1
HU - Ungheria 1
KH - Cambogia 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
MD - Moldavia 1
MM - Myanmar 1
MU - Mauritius 1
NO - Norvegia 1
OM - Oman 1
PE - Perù 1
RO - Romania 1
RS - Serbia 1
SO - Somalia 1
SR - Suriname 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
Totale 5.269
Città #
Singapore 390
Chandler 319
Ashburn 208
San Jose 183
New York 98
Beijing 87
Dublin 74
Ho Chi Minh City 65
Los Angeles 60
Jakarta 47
Milan 47
Hanoi 44
Lauterbourg 42
Warsaw 42
Tokyo 41
The Dalles 40
San Mateo 37
Princeton 35
Rome 35
Hong Kong 34
Boston 33
Dallas 31
Helsinki 31
Wilmington 31
Bremen 29
Marseille 28
Frankfurt am Main 24
Moscow 23
Hefei 22
Munich 22
São Paulo 22
Fairfield 18
Redwood City 18
Atlanta 17
Cattolica 17
Chicago 16
Baghdad 15
Woodbridge 15
Santa Clara 14
Augusta 13
Paris 13
Buffalo 12
Houston 12
Seattle 12
St Louis 12
Da Nang 11
Dearborn 10
Haiphong 10
Pune 10
Turku 10
Abidjan 9
Denver 9
Jacksonville 9
London 9
North Bergen 9
Orem 9
Brooklyn 8
Düsseldorf 8
Falkenstein 8
Rio de Janeiro 8
Seoul 8
Amsterdam 7
Montreal 7
Nuremberg 7
Phoenix 7
Roubaix 7
Saint Louis 7
Stockholm 7
Vienna 7
Washington 7
Belo Horizonte 6
Brasília 6
Brussels 6
Florence 6
Groningen 6
Kent 6
Lappeenranta 6
Memphis 6
Mumbai 6
Naples 6
Philadelphia 6
San Francisco 6
Ann Arbor 5
Asunción 5
Baku 5
Bari 5
Boardman 5
Brno 5
Curitiba 5
Dhaka 5
Guangzhou 5
Hyderabad 5
Leawood 5
Nanjing 5
Orangeburg 5
Poplar 5
Toronto 5
Tukwila 5
Amman 4
Andover 4
Totale 2.796
Nome #
Adenosine as adjunctive therapy in acute coronary syndrome: a meta-analysis of randomized controlled trials 335
Ticagrelor and preconditioning in patients with stable coronary artery disease (TAPER-S): A randomized pilot clinical trial 240
Impact of coronary stenting on top of medical therapy and of inclusion of periprocedural infarctions on hard composite endpoints in patients with chronic coronary syndromes: a meta-analysis of randomized controlled trials 207
Coronary Atherosclerotic Phenotype and Plaque Healing in Patients with Recurrent Acute Coronary Syndromes Compared with Patients with Long-term Clinical Stability: An in Vivo Optical Coherence Tomography Study 181
Sex-Related Differences in Dilated Cardiomyopathy with a Focus on Cardiac Dysfunction in Oncology 165
ORal anticoagulants In fraGile patients with percutAneous endoscopic gastrostoMy and atrIal fibrillation: the (ORIGAMI) study 158
Comprehensive functional and anatomic assessment of myocardial bridging: Unlocking the Gordian Knot 147
Coronary Atherosclerotic Phenotype and Plaque Healing in Patients with Recurrent Acute Coronary Syndromes Compared with Patients with Long-term Clinical Stability: An in Vivo Optical Coherence Tomography Study 145
Oral anticoagulants in fragile patients with percutaneous endoscopic gastrostomy and atrial fibrillation: the ORIGAMI pilot investigation 142
ORal anticoagulants In fraGile patients with percutAneous endoscopic gastrostoMy and atrIal fibrillation: the (ORIGAMI) study 137
Role of perilipin 2 in microvascular obstruction in patients with ST-elevation myocardial infarction 133
Where Does Inflammation Fit? 130
Antithrombotic therapy in the early phase of non-ST-elevation acute coronary syndromes: A systematic review and meta-analysis 128
Dual quantitative coronary angiography accurately quantifies intracoronary thrombotic burden in patients with acute coronary syndrome: Comparison with optical coherence tomography imaging 125
Intracoronary bolus of glycoprotein IIb/IIIa inhibitor as bridging or adjunctive strategy to oral P2Y12 inhibitor load in the modern setting of STEMI 125
A 3-Year Single Center Experience With Left Atrial Pressure Remote Monitoring: The Long and Winding Road 123
Comparative effects of guided vs. potent P2Y12 inhibitor therapy in acute coronary syndrome: a network meta-analysis of 61 898 patients from 15 randomized trials 123
Venoarterial extracorporeal membrane oxygenation (VA-ECMO) with vs without left ventricular unloading by Impella: a systematic review and meta-analysis 122
Role of perilipin 2 in microvascular obstruction in patients with ST-elevation myocardial infarction 121
Gender-differences in antithrombotic therapy across the spectrum of ischemic heart disease: Time to tackle the Yentl syndrome? 120
Device-based remote monitoring strategies for congestion-guided management of patients with heart failure: a systematic review and meta-analysis 120
Intracranial haemorrhages vs. stent thromboses with direct oral anticoagulant plus single antiplatelet agent or triple antithrombotic therapy: a meta-analysis of randomized trials in atrial fibrillation and percutaneous coronary intervention/acute coronary syndrome patients 115
Experience of Remote Cardiac Care during Covid-19 Pandemic: the V-LAP™ device in advanced heart failure 115
Efficacy and safety of novel oral anticoagulants versus low molecular weight heparin in cancer patients with venous thromboembolism: A systematic review and meta-analysis 115
Genetic testing in patients undergoing percutaneous coronary intervention: rationale, evidence and practical recommendations 113
Pre-stenting residual thrombotic volume assessed by dual quantitative coronary angiography predicts microvascular obstruction in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention 108
Neoatherosclerosis after drug-eluting stent implantation: A novel clinical and therapeutic challenge 103
Telemedicine, Artificial Intelligence and Humanisation of Clinical Pathways in Heart Failure Management: Back to the Future and Beyond 102
Sustained safe and effective anticoagulation using Edoxaban via percutaneous endoscopic gastrostomy 99
Colchicine and risk of non-cardiovascular death in patients with coronary artery disease: A pooled analysis underling possible safety concerns 98
Revascularization strategies versus optimal medical therapy in chronic coronary syndrome: A network meta-analysis 98
Efficacy and safety of dual pathway inhibition in patients with cardiovascular disease: a systematic review and Meta-analysis 97
Very short vs. long dual antiplatelet therapy after second generation drug-eluting stents in 35 785 patients undergoing percutaneous coronary interventions: a meta-analysis of randomized controlled trials 96
How deep is your lesion? Extreme guideliner V3 intubation through RIMA graft to treat a distal left anterior descending artery stenosis 94
Double or triple antithrombotic therapy for patients with atrial fibrillation undergoing percutaneous coronary intervention: Not a matter of faith 93
Response - Letter to the editor: Colchicine and risk of non-cardiovascular death in patients with coronary artery disease: A pooled analysis underlying possible safety concerns 91
Dropping aspirin in patients with atrial fibrillation undergoing percutaneous coronary intervention: A jump with a weak parachute? 88
Early anticoagulation in the current management of NSTE-ACS: Evidence, guidelines, practice and perspectives 82
Do We Need to Define Therapeutic Ranges for Edoxaban Plasma Concentration? 79
Do We Need to Define Therapeutic Ranges for Edoxaban Plasma Concentration? 76
Prevention of atherothrombotic events in patients with diabetes mellitus: from antithrombotic therapies to new-generation glucose-lowering drugs 72
Randomised trials and meta-analyses of double vs triple antithrombotic therapy for atrial fibrillation-ACS/PCI: A critical appraisal 71
Stent Thrombosis With Dual Antithrombotic Therapy in Atrial Fibrillation–ACS/PCI Trials 51
Aspirin in primary prevention of cardiovascular disease in the elderly 48
Totale 5.331
Categoria #
all - tutte 24.476
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.476


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022368 0 11 0 31 12 7 6 45 20 22 152 62
2022/2023921 102 108 65 143 47 124 56 80 136 10 29 21
2023/2024476 20 112 17 55 23 71 45 17 8 20 44 44
2024/2025816 19 14 68 44 65 46 28 39 113 98 165 117
2025/20262.083 349 34 96 233 404 84 417 102 147 131 53 33
2026/2027325 74 251 0 0 0 0 0 0 0 0 0 0
Totale 5.331